Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 3 of 3
Full-Text Articles in Medicine and Health Sciences
Dosimetric Evaluation Of Helical Tomotherapy Treatment Planning For Non-Small Cell Lung Cancer, Karen Chu, George Rodrigues, Slav Yartsev, A. Rashid Dar, Edward Yu, Robert Ash, Brian Yaremko, Marc Mackenzie, Harvey Quon, Glenn Bauman, Wilson Roa
Dosimetric Evaluation Of Helical Tomotherapy Treatment Planning For Non-Small Cell Lung Cancer, Karen Chu, George Rodrigues, Slav Yartsev, A. Rashid Dar, Edward Yu, Robert Ash, Brian Yaremko, Marc Mackenzie, Harvey Quon, Glenn Bauman, Wilson Roa
Edward Yu
Helical tomotherapy (HT) is a novel technique to deliver intensity modulated radiation therapy guided by 3D megavoltage CT imaging. The purpose of our study is to assess the dosimetric parameters related to HT and 3DCRT in advanced non-small cell lung cancer (NSCLC). Eleven patients from the London Regional Cancer Centre and the Cross Cancer Institute with NSCLC underwent individualized treatment planning on both HT and 3DCRT. Corresponding HT and 3DCRT plans for each patient were analyzed using dose-volume histograms for GTV, PTV (median dose 60Gy/30 fractions), and critical structures (lung V5-30, esophageal V50-60, and spinal cord D1). Observed differences in …
Definitive Radiation Therapy Management For Medically Non-Resectable Clinically Localised Non-Small Cell Lung Cancer: Results & Prognostic Factors, Edward Yu, Patricia Tai, Robert Ash, Michael Lee, Larry Stitt, George Rodrigues, Rashid Dar, Mark Vincent, Richard Inculet, Richard Malthaner
Definitive Radiation Therapy Management For Medically Non-Resectable Clinically Localised Non-Small Cell Lung Cancer: Results & Prognostic Factors, Edward Yu, Patricia Tai, Robert Ash, Michael Lee, Larry Stitt, George Rodrigues, Rashid Dar, Mark Vincent, Richard Inculet, Richard Malthaner
Edward Yu
The aim of this paper is to review the experience of radical radiation therapy and the prognostic factors of patient outcome for clinically localised, medically inoperable non-small cell lung cancer (NSCLC) patients. Clinically staged node-negative NSCLC patients who were not a surgical candidates due to co-morbid diseases but who were eligible for curative treatment, were reviewed in the London Regional Cancer Program (LRCP). This study population was treated between 1st Jan 1985 to 31st Jan 2004. Patients were excluded if they were previously treated with chest radiotherapy. Patients with localised disease, but who refused surgery, were also included in the …
Altered Fractionation Of Radical Radiation Therapy In The Management Of Unresectable Non-Small Cell Lung Cancer, E. Yu, K. Lochrin, P. Dixon, Y. Ung, A. Gagliardi, W. K. Evans
Altered Fractionation Of Radical Radiation Therapy In The Management Of Unresectable Non-Small Cell Lung Cancer, E. Yu, K. Lochrin, P. Dixon, Y. Ung, A. Gagliardi, W. K. Evans
Edward Yu
No abstract provided.